Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen

Rapid detection of octamer binding proteins with ‘mini extracts’, prepared from a small number of cells

Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · see citing works

Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma

Kořínek, V., Barker, N., Morin, P. J., van Wichen, D. F., de Weger, R. A., Kinzler, K. W., Vogelstein, B., & Clevers, H. C. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 3,304 · see citing works

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · see citing works

The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Hallcher, L. M., & Sherman, W. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70391-3 · Cited by 1,102 · see citing works

Histone deacetylase inhibitor selectively induces p21 ^WAF1 expression and gene-associated histone acetylation

Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090 · see citing works

Neural and developmental actions of lithium: A unifying hypothesis

Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,016 · see citing works

What's Up and Down with Histone Deacetylation and Transcription?

Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 820 · see citing works

Deacetylation of p53 modulates its effect on cell growth and apoptosis

Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. J. (2000) · Nature · doi:10.1038/35042612 · Cited by 818 · see citing works

Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways

Miller, J. R., Hocking, A. M., Brown, J. D., & Moon, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1203245 · Cited by 689 · see citing works

The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

(1996) · Europe PMC (PubMed Central) · Cited by 659 · see citing works

Activation of the Wnt Signaling Pathway: A Molecular Mechanism for Lithium Action

Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H., Lee, V. M.-Y., & Klein, P. S. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8552 · Cited by 637 · see citing works

Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation.

Lint, C. M. V., Emiliani, S., Ott, M., & Verdin, E. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 579 · see citing works

HDAC4 deacetylase associates with and represses the MEF2 transcription factor

Miska, E. A., Karlsson, C., Langley, E., Nielsen, S. J., Pines, J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5099 · Cited by 551 · see citing works

MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS

Robert, E., & Guibaud, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90908-4 · Cited by 545 · see citing works

Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.

Greenberg, S. G., Davies, P., Schein, J., & Binder, L. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48531-6 · Cited by 542 · see citing works

Molecular Targets of Lithium Action

Phiel, C. J., & Klein, P. S. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 513 · see citing works

The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 439 · see citing works

Isolation and Characterization of cDNAs Corresponding to an Additional Member of the Human Histone Deacetylase Gene Family

Yang, W., Yao, Y., Sun, J.-M., Davie, J., & Seto, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28001 · Cited by 433 · see citing works

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N -methyl- d -aspartate receptor-mediated calcium influx

Nonaka, S., Hough, C. J., & Chuang, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 430 · see citing works

Mechanisms of action of valproate: a commentatory

Johannessen, C. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00013-9 · Cited by 400 · see citing works

Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects

Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H. W., & Cohen, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34940 · Cited by 390 · see citing works

Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathwayPreprint

Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., & Lazar, M. A. (2000) · Genes & Development · doi:10.1101/gad.14.1.45 · Cited by 325 · see citing works

Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

Nau, H., Hauck, R.-S., & Ehlers, K. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb01303.x · Cited by 301 · see citing works

Definition of insanity.

Wt, W. (1984) · PubMed · Cited by 289 · see citing works

Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein

David, G., Alland, L., Hong, S.-H., Wong, C.-W., DePinho, R. A., & Dejean, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202043 · Cited by 281 · see citing works

[Pharmacodynamic properties of N-dipropylacetic acid].

Meunier, H., Carraz, G., Neunier, Y., et al. (1998) · PubMed · Cited by 250 · see citing works

Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system

Dickinson, M. E., Krumlauf, R. K., & McMahon, A. P. (1994) · Development · doi:10.1242/dev.120.6.1453 · Cited by 243 · see citing works

Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness

Manji, H. K., & Lenox, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00235-8 · Cited by 241 · see citing works

A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin

Thomas, G. M., Frame, S., Goedert, M., Näthke, I. S., Polakis, P. G., & Cohen, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01161-8 · Cited by 229 · see citing works

β-Catenin–Histone Deacetylase Interactions Regulate the Transition of LEF1 from a Transcriptional Repressor to an Activator

Billin, A. N., Thirlwell, H., & Ayer, D. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6882-6890.2000 · Cited by 216 · see citing works

Cloning and characterization of a novel human histone deacetylase, HDAC8

BUGGY, J. J., SIDERIS, M. L., MAK, P., LORIMER, D. D., MCINTOSH, B., & CLARK, J. M. (2000) · Biochemical Journal · doi:10.1042/bj3500199 · Cited by 197 · see citing works

A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegansPreprint

Shi, Y., & Mello, C. C. (1998) · Genes & Development · doi:10.1101/gad.12.7.943 · Cited by 166 · see citing works

Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure.

York, J. D., Ponder, J. W., & Majerus, P. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5149 · Cited by 159 · see citing works

NURD-complex genes antagonise Ras-induced vulval development in Caenorhabditis elegans

Solari, F., & Ahringer, J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00343-2 · Cited by 153 · see citing works

Histone deacetylase inhibitors as potential anti-skin cancer agents.

Saunders, N. A., Dicker, T., Popa, C., Jones, S. J. M., & Dahler, A. L. (1999) · PubMed · Cited by 137 · see citing works

Lithium and Valproate Decrease Inositol Mass and Increase Expression of the Yeast INO1 and INO2Genes for Inositol Biosynthesis

Vaden, D. L., Ding, D., Peterson, B. C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004179200 · Cited by 131 · see citing works

Lithium Protects Rat Cerebellar Granule Cells against Apoptosis Induced by Anticonvulsants, Phenytoin and Carbamazepine

Nonaka, S., Katsube, N. C., & Chuang, D.-M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37615-3 · Cited by 131 · see citing works

Histone Acetylation Influences both Gene Expression and Development of Xenopus laevis

Almouzni, G., Khochbin, S., Dimitrov, S. I., & Wolffe, A. P. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1283 · Cited by 130 · see citing works

Neurobiology of lithium: an update.

Lenox, R. H., McNamara, R. K., Papke, R. L., & Manji, H. K. (1998) · PubMed · Cited by 125 · see citing works

Mechanisms of action of antiepileptic drugs

Davies, J. A. (1995) · Seizure · doi:10.1016/s1059-1311(95)80003-4 · Cited by 117 · see citing works

The Rpd3 histone deacetylase is required for segmentation of the Drosophila embryo

Mannervik, M., & Levine, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6797 · Cited by 113 · see citing works

Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.

Huang, H., Reed, C. P., Zhang, J. S., Shridhar, V., Wang, L., & Smith, D. I. (1999) · PubMed · Cited by 111 · see citing works

Different mechanisms of protection against apoptosis by valproate and Li+

Mora, A., González‐Polo, R. A., Fuentes, J. M., Soler, G., & Centeno, F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00919.x · Cited by 101 · see citing works

Valproate robustly enhances AP-1 mediated gene expression

Chen, G., Yuan, P.-X., Jiang, Y., Huang, L., & Manji, H. K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00303-9 · Cited by 101 · see citing works

The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns

Svensson, K., Mattsson, R., James, T. C., Wentzel, P., Pilartz, M., MacLaughlin, J., Miller, S. J., Olsson, T., Eriksson, U. J., & OHLSSON, R. I. (1998) · Development · doi:10.1242/dev.125.1.61 · Cited by 101 · see citing works

Differential Display PCR Reveals Novel Targets for the Mood-Stabilizing Drug Valproate Including the Molecular Chaperone GRP78

Wang, J., Bown, C. D., & Young, L. T. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12177-3 · Cited by 96 · see citing works

Xwnt-8 and lithium can act upon either dorsal mesodermal or neurectodermal cells to cause a loss of forebrain in Xenopus embryos

Fredieu, J. R., Cui, Y., Maier, D., Danilchik, M. V., & Christian, J. L. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8566 · Cited by 87 · see citing works

Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.

Bordonaro, M., Mariadason, J. M., Aslam, F., et al. (1999) · PubMed · Cited by 87 · see citing works

Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells

Asghari, V., Wang, J. F., Reiach, J. S., et al. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00107-7 · Cited by 83 · see citing works

The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates

Dixon, J. F., & Hokin, L. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4757 · Cited by 77 · see citing works

Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells

Staal, F. J. T., Burgering, B. M. T., van de Wetering, M., & Clevers, H. C. (1999) · International Immunology · doi:10.1093/intimm/11.3.317 · Cited by 75 · see citing works

Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate

Murray, M., & Greenberg, M. L. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01886.x · Cited by 72 · see citing works

Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos

Naruse, I., Collins, M. D., & Scott, W. J. (1988) · Teratology · doi:10.1002/tera.1420380113 · Cited by 66 · see citing works

Myo-Inositol Monophosphatase: Diverse Effects of Lithium, Carbamazepine, and Valproate

Vadnal, R. E. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00088-h · Cited by 61 · see citing works

Signalling pathways in the brain: Cellular transduction of mood stabilisation in the treatment of manic-depressive illness

Manji, H. K., McNamara, R. K., Chen, G., & Lenox, R. H. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.1999.00670.x · Cited by 60 · see citing works

New Molecular Bioassays for the Estimation of the Teratogenic Potency of Valproic Acid Derivatives in Vitro: Activation of the Peroxisomal Proliferator-Activated Receptor (PPARδ)

Lampen, A., Siehler, S., Ellerbeck, U., Göttlicher, M., & Nau, H. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8770 · Cited by 60 · see citing works

Actions of sodium valproate on the central nervous system.

Tunnicliff, G. (1999) · PubMed · Cited by 59 · see citing works

Valproic acid for the treatment of pediatric malignant glioma

Driever, P. H., Knüpfer, M. M., Cinatl, J. J., & Wolff, J. E. A. (1999) · Klinische Pädiatrie · doi:10.1055/s-2008-1043809 · Cited by 55 · see citing works

Microtubule‐associated Protein Tau, Paired Helical Filaments, and Phosphorylationa

Mandelkow, E., BIERNAT, J., DREWES, G., STEINER, B., LICHTENBERG‐KRAAG, B., WILLE, H., GUSTKE, N., & MANDELKOW, E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23054.x · Cited by 53 · see citing works

Neuronal Differentiation of Neuro 2a Cells by Inhibitors of Cell Cycle Progression, Trichostatin A and Butyrolactone I

Inokoshi, J., Katagiri, M., Arima, S., Tanaka, H., Hayashi, M., Kim, Y. B., Furumai, R., Yoshida, M., Horinouchi, S., & Ōmura, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0316 · Cited by 50 · see citing works

Additive incidence of developmental malformation for Xenopus embryos exposed to a mixture of ten aliphatic carboxylic acids

Dawson, D. A. (1991) · Teratology · doi:10.1002/tera.1420440507 · Cited by 48 · see citing works

The Use of Valproic Acid in HIV-Positive Patients

Jennings, H. R., & Romanelli, F. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.19014 · Cited by 47 · see citing works

Characterization of a Bioengineered Chimeric Na+-Nucleoside Transporter

Wang, J., & Giacomini, K. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.234 · Cited by 31 · see citing works

In vivo uptake of valproic acid into brain

Hammond, E. J., Perchalski, R. J., Villarreal, H. J., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)90664-3 · Cited by 20 · see citing works

Effect of activin and lithium on isolated Xenopus animal blastomeres and response alteration at the midblastula transition

Kinoshita, K., & Asashima, M. (1995) · Development · doi:10.1242/dev.121.6.1581 · Cited by 15 · see citing works

Untitled work

(1999) · doi:10.1002/(sici)1521-1878(199912)22:1

Combination therapy in combating cancer

Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543 · see citing works

Histone deacetylases and cancer: causes and therapies

Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · see citing works

Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777 · see citing works

Phenotypic plasticity and the epigenetics of human disease

Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · see citing works

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515 · see citing works

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066 · see citing works

Multiple roles of HDAC inhibition in neurodegenerative conditions

Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676 · see citing works

Reelin promoter hypermethylation in schizophrenia

Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553 · see citing works

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · see citing works

Valproic acid in pregnancy: how much are we endangering the embryo and fetus?

Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526 · see citing works

Characteristics of fetal anticonvulsant syndrome associated autistic disorder

Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456 · see citing works

Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404 · see citing works

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons

Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358 · see citing works

Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid

Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341 · see citing works

Valproate Induces Replication-independent Active DNA Demethylation

Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345 · see citing works

Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics

Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · see citing works

Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy

Johannessen Landmark, C. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00003 · Cited by 316 · see citing works

Regulation of Ketone Body Metabolism and the Role of PPARα

Grabacka, M., Pierzchalska, M., Dean, M., & Reiss, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122093 · Cited by 305 · see citing works

Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?

Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · see citing works

Enteric Bacterial Metabolites Propionic and Butyric Acid Modulate Gene Expression, Including CREB-Dependent Catecholaminergic Neurotransmission, in PC12 Cells - Possible Relevance to Autism Spectrum Disorders

Nankova, B. B., Agarwal, R., MacFabe, D. F., & La Gamma, E. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103740 · Cited by 294 · see citing works

Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms

Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00053 · Cited by 283 · see citing works

Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

Chen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.053 · Cited by 262 · see citing works

Valproate Induces widespread epigenetic reprogramming which involves demethylation of specific genes

Milutinovic, S., D'Alessio, A. C., Detich, N., & Szyf, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl167 · Cited by 256 · see citing works

Autism Spectrum Disorders and Epigenetics

Grafodatskaya, D., Chung, B., Szatmari, P., & Weksberg, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.005 · Cited by 235 · see citing works

Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease

Codagnone, M. G., Spichak, S., O’Mahony, S. M., O’Leary, O. F., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.014 · Cited by 198 · see citing works

Altered gene expression of histone deacetylases in mood disorder patients

Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., & Watanabe, Y. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.015 · Cited by 185 · see citing works

Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders

Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171 · see citing works

Valproate reopens critical-period learning of absolute pitch

Gervain, J., Vines, B. W., Chen, L. M., Seo, R. J., Hensch, T. K., Werker, J. F., & Young, A. H. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00102 · Cited by 151 · see citing works

Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway

DeCastro, M., Nankova, B. B., Shah, P., Patel, P., Mally, P. V., Mishra, R., & La Gamma, E. F. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.09.002 · Cited by 149 · see citing works

Establishment of intestinal organoid cultures modeling injury-associated epithelial regeneration

Qu, M., Xiong, L., Lyu, Y., Zhang, X., Shen, J., Guan, J., Chai, P., Lin, Z., Nie, B., Li, C., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00453-x · Cited by 138 · see citing works

Antiepileptic drugs and pregnancy outcomes

Wlodarczyk, B. J., Palacios, A. M., George, T. M., & Finnell, R. H. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35438 · Cited by 138 · see citing works

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome

Raffoux, E., Cras, A., Recher, C., Boëlle, P.-Y., de Labarthe, A., Turlure, P., Marolleau, J.-P., Reman, O., Gardin, C., Victor, M., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.106 · Cited by 134 · see citing works

Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein

Venkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057836 · Cited by 133 · see citing works

Epigenetics of drug abuse: predisposition or response

Nielsen, D. A., Utrankar, A., Reyes, J. A., Simons, D. D., & Kosten, T. R. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.94 · Cited by 125 · see citing works

Antiepileptic drugs and the developing brain

Kaindl, A. M., Asimiadou, S., Manthey, D., Hagen, M. V. D., Turski, L., & Ikonomidou, C. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5348-0 · Cited by 121 · see citing works

Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition

Kidd, S. K., & Schneider, J. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.041 · Cited by 113 · see citing works

The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability

Gomes, F. V., Zhu, X., & Grace, A. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0514-1 · Cited by 91 · see citing works

Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications

Szyf, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.009 · Cited by 76 · see citing works

Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.

Krystal, J. H., Tolin, D. F., Sanacora, G., Castner, S. A., Williams, G. V., Aikins, D. E., Hoffman, R. E., & D'Souza, D. C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.002 · Cited by 76 · see citing works

Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys

Torrioli, M., Vernacotola, S., Setini, C., Bevilacqua, F., Martinelli, D., Snape, M., Hutchison, J. A., Di Raimo, F. R., Tabolacci, E., & Neri, G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33484 · Cited by 71 · see citing works

Synergistic effects of sodium butyrate, a histone deacetylase inhibitor, on increase of neurogenesis induced by pyridoxine and increase of neural proliferation in the mouse dentate gyrus

Yoo, D. Y., Kim, W., Nam, S. M., Kim, D. W., Chung, J. Y., Choi, S. Y., Yoon, Y. S., Won, M.-H., & Hwang, I. K. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0503-5 · Cited by 60 · see citing works

Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors

Halsall, J., Gupta, V., O'Neill, L. P., Turner, B. M., & Nightingale, K. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033453 · Cited by 57 · see citing works

Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures

Gibbons, H. M., Smith, A. M., Teoh, H. H., Bergin, P. M., Mee, E. W., Faull, R. L. M., & Dragunow, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.024 · Cited by 49 · see citing works

Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism

Sabers, A., Bertelsen, F. C. B., Scheel-Krüger, J., Nyengaard, J. R., & Møller, A. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.036 · Cited by 43 · see citing works

Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation

Tabolacci, E., De Pascalis, I., Accadia, M., Terracciano, A., Moscato, U., Chiurazzi, P., & Neri, G. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830500a1 · Cited by 44 · see citing works

Environmental epigenomics: understanding the effects of parental care on the epigenome

McGowan, P. O., & Szyf, M. (2010) · Essays in Biochemistry · doi:10.1042/bse0480275 · Cited by 39 · see citing works

Association of DNA Methylation with Acute Mania and Inflammatory Markers

Sabunciyan, S., Maher, B., Bahn, S., Dickerson, F., & Yolken, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132001 · Cited by 35 · see citing works

Epigenetic histone acetylation and Bdnf dysregulation in the hippocampus of rats exposed to repeated, low-dose diisopropylfluorophosphate

Ribeiro, A. C. R., Jahr, F. M., Hawkins, E., Kronfol, M. M., Younis, R. M., McClay, J. L., & Deshpande, L. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119765 · Cited by 30 · see citing works

Valproic Acid: Update on Its Mechanisms of Action

Johnston, D. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb05630.x · Cited by 62 · see citing works

Anticonvulsant activity of metabolites of valproic acid.

Löscher, W. (1981) · PubMed · Cited by 43 · see citing works

Novel phosphinic and phosphonic acid analogues of the anticonvulsant valproic acid

Kehler, J., Hansen, H. I., & Sánchez, C. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00512-6 · Cited by 9 · see citing works

Development of tolerance in the anticonvulsant effect of valproic acid in rats exposed prenatally to valproic acid

Fujii, T., Hara, N., & Kuga, Y. (1985) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)63792-3

Valproic Acid

Snodgrass, W. R., & Hsu, C. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_115 · Cited by 1 · see citing works